A 46-year-old Caucasian male with a history of poorly controlled type II diabetes mellitus (DM) and hypertriglyceridemia presented with painless, non-pruritic bumps on his bilateral arms and knees for two weeks. Four weeks previously, the patient had been started on mirtazapine for post-traumatic stress disorder. He denied any past or family history of such rashes. On examination, his skin was remarkable for grouped pink to yellow, well-defined papules on the extensor surfaces of his elbows and knees (Fig. 1). The patient’s laboratory tests showed hyperglycemia (400 mg/dl) and severe hypertriglyceridemia (>3000 mg/dl). Based on his examination and laboratory findings, a diagnosis of eruptive xanthomas in the setting of severe hypertriglyceridemia was made.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.